Health and Healthcare

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Chris Lange | Oct 6, 2020 at 11:05 AM EDT

Why Investors Have to Be Happy With Alexion’s Latest Update

Announcements that Alexion Pharmaceuticals made at its virtual Investor Day about expanding its pipeline and its guidance led to a…

Jon C. Ogg | Oct 6, 2020 at 8:57 AM EDT

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and…

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 10, 2020 at 7:55 AM EDT

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come…

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 5, 2020 at 10:07 AM EDT

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense,…

Jon C. Ogg | Jul 30, 2020 at 6:29 PM EDT

Why Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks

Investors have flocked to the dividends of Big Pharma and flocked to the limitless upside of major biotech outfits for…

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 13, 2020 at 9:43 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Biotechs

The June 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Jun 25, 2020 at 9:46 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 10, 2020 at 10:01 AM EDT

Major Biotechs Have Short Sellers on the Run

The May 29 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | May 29, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Alexion, Ciena, Dell, Dollar General, Dollar Tree, Marvell, PPL, Republic Services, Tesla, VMware, Zscaler and More

Friday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Ciena, Dell Technologies, Dollar General, Dollar Tree, Marvell Technology, PPL, Republic…

1 2 3 4 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Why Investors Have to Be Happy With Alexion’s Latest Update

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Biotech Short Sellers Hike Their Bets

Short Sellers Hike Their Bets in Major Biotechs

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Major Biotechs Scare Off Short Sellers

Short Sellers Shy Away From Big Biotech

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

Why Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Top Analyst Upgrades and Downgrades: Alexion, Ciena, Dell, Dollar General, Dollar Tree, Marvell, PPL, Republic Services, Tesla, VMware, Zscaler and More

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Why Investors Have to Be Happy With Alexion’s Latest Update

Top Analyst Upgrades and Downgrades: Alexion, Bill.com, Boeing, Costco, Generac, Proofpoint, Regeneron, Shopify and More

Biotech Short Sellers Hike Their Bets

Short Sellers Hike Their Bets in Major Biotechs

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Major Biotechs Scare Off Short Sellers

Short Sellers Shy Away From Big Biotech

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19

Why Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks

Big Biotechs Scare Off Short Sellers

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Top Analyst Upgrades and Downgrades: Alexion, Ciena, Dell, Dollar General, Dollar Tree, Marvell, PPL, Republic Services, Tesla, VMware, Zscaler and More

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026